baozhang
voted
Good morning, traders. Happy Friday, and what a Friday it is! Federal Reserve President Jerome Powell said everything short of 'we are cutting rates in September' at the Jackson Hole, WY Economic Symposium this morning. The market reacted positively, with indexes climbing right up to the shoulder of record highs.
My name is Kevin Travers; here are stories about the U.S. stock market today.
$NVIDIA (NVDA.US)$ climbed 4%, the ...
My name is Kevin Travers; here are stories about the U.S. stock market today.
$NVIDIA (NVDA.US)$ climbed 4%, the ...
![Fed Ready to Cut, Market Booms, but Data Will Show When | Moovin Stonks](https://1500015405.vod2.myqcloud.com/57f4fa2avodtransusw1500015405/189f0e371397757891019773068/coverBySnapshot/coverBySnapshot_10_0.jpg)
36
20
$Bio-Path Holdings (BPTH.US)$ Is it low right now?
Translated
baozhang
voted
Good morning, traders. Happy Wednesday. The market is advancing again after pulling back from a nearly ten day climb Tuesday. Retail earnings this morning came in mixed, the DNC is still roaring on in Chicago.
My name is Kevin Travers; here are stories moooving on the U.S. stock market today.
Target Corporation $Target (TGT.US)$ climbed 12% Wednesday after reporting Q2 results that exceeded expectations and boosted its ful...
My name is Kevin Travers; here are stories moooving on the U.S. stock market today.
Target Corporation $Target (TGT.US)$ climbed 12% Wednesday after reporting Q2 results that exceeded expectations and boosted its ful...
![U.S. Stocks Rebound, Retail Companies Facing Inflation Woes | Moovin Stonks](https://1500015405.vod2.myqcloud.com/f7703b98vodtransuse1500015405/fd5690a31397757891304281021/coverBySnapshot/coverBySnapshot_10_0.jpg)
46
7
$Bio-Path Holdings (BPTH.US)$ What's the situation?
Translated
1
1
$Aditxt (ADTX.US)$ I'm so tired because I'm under the duvet again
Translated
$Bone Biologics (BBLG.US)$ What will happen tomorrow?
Translated
1
$CNS Pharmaceuticals (CNSP.US)$ Dilute by falling?
Translated
baozhang
commented on
$CNS Pharmaceuticals (CNSP.US)$ CNS Pharmaceuticals Expands Pipeline With in-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
1